Dexcel Pharma patent expiration

1. Omeprazole patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9023391 DEXCEL PHARMA Stable benzimidazole formulation
Aug, 2025

(1 year, 28 days from now)




Drugs and Companies using OMEPRAZOLE ingredient

Market Authorisation Date: 04 December, 2007

Treatment: NA

Dosage: TABLET, DELAYED RELEASE

More Information on Dosage

OMEPRAZOLE family patents

Family Patents